Literature DB >> 18281293

Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research.

Laura B Dunn1, Daniel S Kim, Ian E Fellows, Barton W Palmer.   

Abstract

OBJECTIVE: Providing incentives for research participation is widely practiced but minimally studied. In schizophrenia research, questions about capacity to consent and potential vulnerability may raise concerns when offering incentives for participation. Despite empirical attention focused on consent and decision-making capacity in schizophrenia, the issue of incentives has been essentially ignored. We examined willingness to participate in research, in relation to perceived risks and benefits, among people with schizophrenia and schizoaffective disorder.
METHOD: Forty-six people with schizophrenia or schizoaffective disorder rated perceived risks and benefits of 5 hypothetical research vignettes. They also indicated whether they would be willing to participate at each of 5 incentive levels (including no compensation). Cognition was assessed with Mattis Dementia Rating Scale.
RESULTS: Ratings of risk and potential personal benefit were inversely correlated. For all scenarios, significant correlations were found between perceived risk and willingness to participate for greater compensation. Conversely, lower perceived likelihood of benefit was associated with a higher compensation threshold for participation in each scenario. Even at the highest proffered payment level for each scenario, however, a substantial proportion of respondents were not willing to participate. Risk assessment and willingness to participate (at all levels of compensation) were not associated with demographic variables or cognitive status.
CONCLUSIONS: Determining whether incentives impede voluntarism remains an important task for empirical ethics research. Assessing potential research participants' understanding and perceptions of risks, benefits, and alternatives to participation will help ensure that informed consent fulfills its mission--embodying the ethical principle of respect for persons.

Entities:  

Mesh:

Year:  2008        PMID: 18281293      PMCID: PMC2696364          DOI: 10.1093/schbul/sbn003

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  43 in total

Review 1.  Informed consent and the capacity for voluntarism.

Authors:  Laura Weiss Roberts
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

2.  Inducement in research.

Authors:  Martin Wilkinson; Andrew Moore
Journal:  Bioethics       Date:  1997-10       Impact factor: 1.898

Review 3.  Ethical considerations in psychopharmacological research involving decisionally impaired subjects.

Authors:  Donald L Rosenstein; Franklin G Miller
Journal:  Psychopharmacology (Berl)       Date:  2003-05-28       Impact factor: 4.530

4.  Willingness of subjects with thought disorder to participate in research.

Authors:  Philip J Candilis; Cynthia M A Geppert; Kenneth E Fletcher; Charles W Lidz; Paul S Appelbaum
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

5.  Ethics in human subjects research: do incentives matter?

Authors:  Ruth W Grant; Jeremy Sugarman
Journal:  J Med Philos       Date:  2004-12

6.  Perspectives of patients with schizophrenia and psychiatrists regarding ethically important aspects of research participation.

Authors:  L W Roberts; T D Warner; J L Brody
Journal:  Am J Psychiatry       Date:  2000-01       Impact factor: 18.112

7.  Ethical issues in schizophrenia research: a commentary on some current concerns.

Authors:  David Shore
Journal:  Schizophr Bull       Date:  2005-11-30       Impact factor: 9.306

8.  Assessments by patients with schizophrenia and psychiatrists of relative risk of research procedures.

Authors:  Laura Weiss Roberts; Teddy D Warner; Katherine Green Hammond; Laura B Dunn
Journal:  Psychiatr Serv       Date:  2006-11       Impact factor: 3.084

9.  Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument.

Authors:  Laura B Dunn; Barton W Palmer; Monique Keehan; Dilip V Jeste; Paul S Appelbaum
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

10.  Schizophrenia research participants' responses to protocol safeguards: recruitment, consent, and debriefing.

Authors:  Laura Weiss Roberts; Teddy D Warner; Charles T Anderson; Megan V Smithpeter; Melinda K Rogers
Journal:  Schizophr Res       Date:  2004-04-01       Impact factor: 4.939

View more
  16 in total

1.  Screening for understanding of research in the inpatient psychiatry setting.

Authors:  Norval J Hickman; Judith J Prochaska; Laura B Dunn
Journal:  J Empir Res Hum Res Ethics       Date:  2011-09       Impact factor: 1.742

2.  Incentives for research participation: policy and practice from Canadian corrections.

Authors:  Flora I Matheson; Pamela Forrester; Amanda Brazil; Sherri Doherty; Lindy Affleck
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

3.  Attitudes of Mothers Regarding Willingness to Enroll Their Children in Research.

Authors:  Jane Paik Kim; Maryam Rostami; Laura Weiss Roberts
Journal:  J Empir Res Hum Res Ethics       Date:  2020-06-18       Impact factor: 1.742

4.  Addressing risks to advance mental health research.

Authors:  Ana S Iltis; Sahana Misra; Laura B Dunn; Gregory K Brown; Amy Campbell; Sarah A Earll; Anne Glowinski; Whitney B Hadley; Ronald Pies; James M Dubois
Journal:  JAMA Psychiatry       Date:  2013-12       Impact factor: 21.596

5.  Is It Worth It? Benefits in Research With Adults With Intellectual Disability.

Authors:  Katherine E McDonald; Nicole E Conroy; Robert S Olick
Journal:  Intellect Dev Disabil       Date:  2016-12

6.  Randomized evaluation of trial acceptability by INcentive (RETAIN): Study protocol for two embedded randomized controlled trials.

Authors:  Dustin C Krutsinger; Jacqueline McMahon; Alisa J Stephens-Shields; Brian Bayes; Steven Brooks; Brian L Hitsman; Su Fen Lubitz; Celine Reyes; Robert A Schnoll; S Ryan Greysen; Ashley Mercede; Mitesh S Patel; Catherine Reale; Fran Barg; Jason Karlawish; Daniel Polsky; Kevin G Volpp; Scott D Halpern
Journal:  Contemp Clin Trials       Date:  2018-11-08       Impact factor: 2.226

7.  Typologies of Altruistic and Financial Motivations for Research Participation.

Authors:  Lisa J Chin; Jacqueline A Berenson; Robert L Klitzman
Journal:  J Empir Res Hum Res Ethics       Date:  2016-10       Impact factor: 1.742

8.  Ethics in Psychiatric Research: A Review of 25 Years of NIH-funded Empirical Research Projects.

Authors:  James Dubois; Holly Bante; Whitney B Hadley
Journal:  AJOB Prim Res       Date:  2011-12-06

9.  Bioethical Issues in Providing Financial Incentives to Research Participants.

Authors:  David B Resnik
Journal:  Medicoleg Bioeth       Date:  2015-06-24

10.  Negative association of perceived risk and willingness to participate in innovative psychiatric research protocols.

Authors:  Tenzin Tsungmey; Jane Paik Kim; Laura B Dunn; Katie Ryan; Kyle Lane-McKinley; Laura Weiss Roberts
Journal:  J Psychiatr Res       Date:  2019-12-18       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.